Abstract:The aim of this study was to explore the clinical effect of montelukast sodium chewable tablets combined with inhaled budesonide in the treatment of pediatric asthma and its influence on inflammatory factors. One hundred and thirty-five asthmatic children were randomly divided into montelukast sodium group, budesonide group and combined group. Clinical symptoms, lung function, inflammatory factors and immune related indices of patients in each group were observed and recorded. After treatment, the times to disappearance of wheezes, dyspnea, asthma and hospital stay in the combined group were significantly shorter than those in the single-drug group (all p < 0.001). Forced vital capacity (FVC), forced expiratory volume in the first second (FEV1), peak expiratory flow (PEF) were significantly higher than those before treatment, and in the combined group value were significantly higher than in the single-drug group in the same period (all p < 0.001). Tumor necrosis factor-alpha (TNF-alpha), interleukin-4 (IL- 4), IL-8 and hypersensitive C-reactive protein (hs-CRP) were significantly lower than before treatment, and the combined group was significantly lower than the single-drug group in the same period (all p < 0.05). The number of CD4(+) and CD3(+) cells in the combined group was significantly higher than that in the single-drug group, while the number of CD8(+) cells and the expression level of immune globulin E (IgE) were significantly lower (all p < 0.05). There was no difference in the incidence of adverse reactions between the groups during treatment (p > 0.05). Six months after treatment, the incidence of asthma in the combined group was significantly lower than that in the single-drug group (both p < 0.05). Montelukast sodium chewable tablets combined with inhaled budesonide can shorten the discomfort duration of asthmatic children and help them restore lung function. Moreover, it reduces the level of inflammatory factors and increases the resistance of children, which is worthy of further promotion and application.

Efficacy of montelukast sodium chewable tablets combined with inhaled budesonide in treating pediatric asthma and its effect on inflammatory factors.

Effect of montelukast on the apoptosis of eosinophil in bronchoalveloar lavage fluid

The Efficacy of Montelukast Combined with Budesonide in Asthma Patients and the Combination’s Effects on the Patients’ Immune and Pulmonary Functions

Changes of Eosinophils in Bronchoalveolar Lavage Fluid of Asthma in Children and the Modulation Effect of Montelukast

Clinical Study Of The Treatment Of Variant Asthma In Children Through Nebulized Inhalation Of Montelukast Combined With Different Doses Of Budesonide Suspension

Clinical Observation of Montelukast Prevention for Wheezing Infants and Young Children after Brochiolitis

Efficacy of add-on montelukast in nonasthmatic eosinophilic bronchitis: the additive effect on airway inflammation, cough and life quality.

Efficacy of Add-on Montelukast in Nonasthmatic Eosinophilic Bronchitis

Efficacy and Safety of Montelukast Sodium Tablets Combined with Budesonide Suspension in the Treatment of Patients with Bronchial Asthma

Treatment of Pediatric Mild Persistent Asthma with Low-Dose Budesonide Inhalation Suspension Vs.montelukast in China

Children with mild to moderate asthma efficacy of montelukast therapy

Budesonide/Fomoterol in combination with Montelukast in the treatment of Bronchial Asthma.

The Efficacy of Montelukast on the Airway Hyperresponsiveness in Children with Asthmatic Bron-chitis

Analysis of the clinical value of montelukast in treating the children with Infantile bronchial asthma

Combining montelukast with exercise in the clinical treatment of children with mild asthma

Discussion on Clinical Value of Budesonide Combine with Montelukast to Improve Pulmonary Function for Pediatric Asthma

Effect of long time oral montelukast on pulmonary function and allergy index of patients with slight and moderate asthma

Effect of Montelukast in the Combined De-escalation Therapy for Infantile Acute Wheezing

Efficacy of Treatment with Montelukast, Fluticasone Propionate and Budesonide Liquid Suspension for the Prevention of Recurrent Asthma Paroxysms in Children with Wheezing Disorders

A Meta-analysis of salmeterol fluticasone combined with montelukast in the treatment of asthma in children

Effects of Budesonide Plus Vitamin AD on Children with Bronchial Asthma and the Effect on Serum IgE and C-reactive Protein